Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibodies in Drug Discovery

Michael Hust's Biography



Michael Hust, Professor, Technical University of Braunschweig

Michael Hust studied biology at the Carl von Ossietzky Universität in Oldenburg, Germany, from 1993-1999. He received his PhD from the Leibniz Universität in Hannover, Germany, in 2002. Since end of 2002 he is working as group leader at the Technische Universität Braunschweig, Germany. In 2011, he finished his professorial dissertation (Habilitation, venia legendi for biotechnology) and was appointed as Privatdozent (PD). In 2014 he was appointed as professor for biotechnology.
He published more than 100 articles (including book chapters and reviews) on antibody engineering and phage display. He is working on the development of human and human-like antibodies for proteome research, diagnostics and therapy with a focus on pathogens and toxins. Another field of interest is the identification of biomarkers of pathogens using phage display.
He co-founded two biotech companies, the mAb-Factory GmbH in 2007 and the YUMAB GmbH (www.yumab.com) in 2012.

Michael Hust Image

Developing Human and Human-like Antibodies for Biodefense

Tuesday, 7 March 2017 at 11:15

Add to Calendar ▼2017-03-07 11:15:002017-03-07 12:15:00Europe/LondonDeveloping Human and Human-like Antibodies for BiodefenseSELECTBIOenquiries@selectbiosciences.com

The development of protective antibodies against alphaviruses, Marburg virus and botulinum toxins will be presented.


Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAntibodies in Drug DiscoverySELECTBIOenquiries@selectbiosciences.com